NCT03896815No Longer Available不适用
Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
Expanded access use of INCB054329 to treat a single patient with metastatic renal cell carcinoma.
研究设计
- 研究类型
- Expanded Access
入排标准
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
No Longer Available
不适用
Expanded Access Use of INCB052793 to Treat a Single Patient With MyelofibrosisNCT03906344Incyte Corporation
已完成
不适用
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248Metastatic Renal Cell CarcinomaNCT00531544King Faisal Specialist Hospital & Research Center350
No Longer Available
不适用
Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic CancerNCT03906357Incyte Corporation
Available
不适用
Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 MutationAdvanced Non-small Cell Lung CancerCancerNCT06761976Bayer
暂停
1 期
68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCCClear Cell Renal Cell CarcinomaNCT06649682Peking Union Medical College Hospital20